Helix BioPharma Corp. (TSX:HBP)
Canada · Delayed Price · Currency is CAD 0.9000
0.00 (0.00%)
Nov 5, 2026, 2:41 PM EST
Helix BioPharma Market Cap
Helix BioPharma has a market cap or net worth of CAD 68.74 million as of November 6, 2026. It is the 29,993rd most valuable company in the world and the 823rd biggest in Canada. Its market cap has decreased by 56.10% in one year.
Market Cap
68.74M
Enterprise Value
72.09M
Revenue
n/a
Global Rank
Country Rank
#823 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since August 15, 1995, Helix BioPharma's market cap has increased from 9.38M to 68.74M, an increase of 632.57%. That is a compound annual growth rate of 6.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 68.74M | -62.03% |
| Dec 31, 2025 | 181.02M | 314.90% |
| Dec 31, 2024 | 43.63M | -4.12% |
| Dec 29, 2023 | 45.50M | 5.81% |
| Dec 30, 2022 | 43.00M | 0.61% |
| Dec 31, 2021 | 42.74M | -36.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eastwood Bio-Medical Canada | 123.99M |
| NurExone Biologic | 47.23M |
| Thiogenesis Therapeutics | 44.09M |
| Sharp Therapeutics | 43.26M |
| Sernova Biotherapeutics | 41.54M |
| Medicenna Therapeutics | 41.07M |
| Microbix Biosystems | 39.72M |
| MedMira | 38.60M |